2,3,4,6-tetrachlorophenol has been researched along with lacosamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brigo, F; Del Giovane, C; Lattanzi, S; Russo, E; Silvestrini, M; Striano, P; Trinka, E; Zaccara, G | 1 |
| Ángel Calleja, M; Gil, A; Navarro, A; Serratosa, JM; Subías Labazuy, S; Toledo, M; Villanueva, V | 1 |
1 review(s) available for 2,3,4,6-tetrachlorophenol and lacosamide
| Article | Year |
|---|---|
Third-Generation Antiseizure Medications for Adjunctive Treatment of Focal-Onset Seizures in Adults: A Systematic Review and Network Meta-analysis.
Topics: Adult; Anticonvulsants; Carbamates; Chlorophenols; Dibenzazepines; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lacosamide; Male; Middle Aged; Network Meta-Analysis; Nitriles; Pyridones; Pyrrolidinones; Randomized Controlled Trials as Topic; Seizures; Tetrazoles | 2022 |
1 other study(ies) available for 2,3,4,6-tetrachlorophenol and lacosamide
| Article | Year |
|---|---|
Determination of the economically justifiable price of cenobamate in the treatment of focal-onset seizures in adult patients with drug-resistant epilepsy in Spain.
Topics: Adult; Carbamates; Chlorophenols; Cost-Benefit Analysis; Epilepsy; Humans; Lacosamide; Quality-Adjusted Life Years; Spain; Tetrazoles | 2022 |